Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > NIH Weekly Funding Opportunities, Notices: June 15, 2018

NIH Weekly Funding Opportunities, Notices: June 15, 2018



 Notices

Requests for Applications

     

  • Sustained Release Innovation for HIV (SRI) (R61/R33 Clinical Trial Optional)
    (RFA-AI-18-006)
    National Institute of Allergy and Infectious Diseases
    National Institute of Mental Health
    Application Receipt Date(s): November 30, 2018, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on this date. 

     

  • Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)
    (RFA-AI-18-023)
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): October 4, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    (RFA-CA-18-015)
    National Cancer Institute
    Application Receipt Date(s): August 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
    (RFA-CA-18-016)
    National Cancer Institute
    Application Receipt Date(s): August 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UG1 Clinical Trial Required)
    (RFA-CA-18-017)
    National Cancer Institute
    Application Receipt Date(s): August 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)
    (RFA-DK-18-009)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 14, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. 

     

  • Large Animal Testing Centers for Evaluation of Somatic Cell Genome Editing Tools (U42 - Clinical Trial Not Allowed)
    (RFA-RM-18-014)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): August 24, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
Program Announcements

     

  • Minor Use Minor Species Development of Drugs (R01)
    (PAR-18-827)
    Food and Drug Administration
    Application Receipt Date(s): August 27, 2018; January 18, 2019; August 16, 2019; January 17, 2020; August 14, 2020; January 15, 2021 by 11:59 PM Eastern Time Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA. 

     

  • NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
    (PAR-18-828)
    National Center for Complementary and Integrative Health
    Office of Dietary Supplements
    Application Receipt Date(s): New Applications: August 31, 2018; February 7, 2019; and October 8, 2019by 5:00 PM local time of applicant organization. Resubmission Applications: September 7, 2018; February 21, 2019; and October 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
    (PAR-18-829)
    National Center for Complementary and Integrative Health
    Office of Dietary Supplements
    Application Receipt Date(s): New Applications: August 31, 2018; February 7, 2019; and October 8, 2019by 5:00 PM local time of applicant organization. Resubmission Applications: September 7, 2018; February 21, 2019; and October 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
    (PAR-18-830)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Cancer Institute
    National Eye Institute
    Application Receipt Date(s): November 7, 2018, June 3, 2019, March 3, 2020, November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
    (PAR-18-831)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): November 7, 2018, June 3, 2019, March 3, 2020, November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.